Clinical Trials Browser

NIH × Genetic Testing × Clear all

NCT06058377 2026-03-18

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Phase 3 Recruiting

Anatomic Stage II Breast Cancer AJCC v8

NCT00900354 2013-08-12

Pharmacokinetics of Dactinomycin in Young Patients With Cancer

Other solid neoplasm

Unspecified Childhood Solid Tumor, Protocol Specific